Near-infrared spectroscopy monitoring during out-of-hospital cardiac arrest: can the initial cerebral tissue oxygenation index predict ROSC?


Journal

Emergency medicine journal : EMJ
ISSN: 1472-0213
Titre abrégé: Emerg Med J
Pays: England
ID NLM: 100963089

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 06 02 2018
revised: 23 10 2018
accepted: 25 10 2018
pubmed: 18 11 2018
medline: 14 6 2019
entrez: 18 11 2018
Statut: ppublish

Résumé

Near-infrared spectroscopy is a modality that can monitor tissue oxygenation index (TOI) and has potential to evaluate return of spontaneous circulation (ROSC) during cardiopulmonary resuscitation (CPR). This study's objectives were to evaluate whether TOI could be associated with ROSC and used to help guide the decision to either terminate CPR or proceed to extracorporeal CPR (ECPR). In this observational study, we assessed the patients with out-of-hospital cardiac arrest with non-traumatic cause receiving CPR on arrival at our ED between 2013 and 2016. TOI monitoring was discontinued either on CPR termination after ROSC was reached or on patient death. Patients were classified into two groups: ROSC and non-ROSC group. Out of 141 patients, 24 were excluded and the remaining 117 were classified as follows: ROSC group (n=44) and non-ROSC group (n=73). ROSC group was significantly younger and more likely to have their event witnessed and bystander CPR. ROSC group showed a higher initial TOI than non-ROSC group (60.5%±17.0% vs 37.9%±13.7%: p<0.01). Area under the curve analysis was more accurate with the initial TOI than without it for predicting ROSC (0.88, 95% CI 0.82 to 0.95 vs 0.79, 95% CI 0.70 to 0.87: p<0.01). TOI cut-off value ≥59% appeared to favour survival to hospital discharge whereas TOI ≤24% was associated with non-ROSC. This study demonstrated an association between higher initial TOI and ROSC. Initial TOI could increase the accuracy of ROSC prognosis and may be a clinical factor in the decision to terminate CPR and select patients who are to proceed to ECPR.

Identifiants

pubmed: 30446504
pii: emermed-2018-207533
doi: 10.1136/emermed-2018-207533
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

33-38

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Jumpei Tsukuda (J)

Department of Emergency and Critical Care Medicine, St Marianna University School of Medicine, Kawasaki, Japan.

Shigeki Fujitani (S)

Department of Emergency and Critical Care Medicine, St Marianna University School of Medicine, Kawasaki, Japan.

Kenichiro Morisawa (K)

Department of Emergency and Critical Care Medicine, St Marianna University School of Medicine, Kawasaki, Japan.

Nobuhiko Shimozawa (N)

Department of Emergency and Critical Care Medicine, St Marianna University School of Medicine, Kawasaki, Japan.

Brandon D Lohman (BD)

Department of Emergency and Critical Care Medicine, St Marianna University School of Medicine, Kawasaki, Japan.

Kentaro Okamoto (K)

Department of Emergency and Critical Care Medicine, St Marianna University School of Medicine, Kawasaki, Japan.

Takeshi Kawaguchi (T)

Department of Emergency and Critical Care Medicine, St Marianna University School of Medicine, Kawasaki, Japan.

Yuka Takamatsu (Y)

Department of Emergency and Critical Care Medicine, St Marianna University School of Medicine, Kawasaki, Japan.

Shuichi Fujii (S)

Department of Emergency and Critical Care Medicine, St Marianna University School of Medicine, Kawasaki, Japan.

Masayuki Ozaki (M)

Department of Emergency and Critical Care Medicine, St Marianna University School of Medicine, Kawasaki, Japan.

Mahbubur Rahman (M)

Graduate School of Public Health, St Luke's International University, Tsukiji, Japan.

Yasuhiko Taira (Y)

Department of Emergency and Critical Care Medicine, St Marianna University School of Medicine, Kawasaki, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH